241 related articles for article (PubMed ID: 10494618)
1. Pharmaceutical perspectives of nonviral gene therapy.
Mahato RI; Smith LC; Rolland A
Adv Genet; 1999; 41():95-156. PubMed ID: 10494618
[TBL] [Abstract][Full Text] [Related]
2. Nonviral gene therapy.
Li S; Ma Z
Curr Gene Ther; 2001 Jul; 1(2):201-26. PubMed ID: 12108955
[TBL] [Abstract][Full Text] [Related]
3. Muscular gene transfer using nonviral vectors.
Braun S
Curr Gene Ther; 2008 Oct; 8(5):391-405. PubMed ID: 18855634
[TBL] [Abstract][Full Text] [Related]
4. Marker-free plasmids for biotechnological applications - implications and perspectives.
Oliveira PH; Mairhofer J
Trends Biotechnol; 2013 Sep; 31(9):539-47. PubMed ID: 23830144
[TBL] [Abstract][Full Text] [Related]
5. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines.
Ochiya T; Nagahara S; Sano A; Itoh H; Terada M
Curr Gene Ther; 2001 May; 1(1):31-52. PubMed ID: 12109137
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of nonviral gene transfer in the canine brain.
Oh S; Pluhar GE; McNeil EA; Kroeger KM; Liu C; Castro MG; Lowenstein PR; Freese A; Ohlfest JR
J Neurosurg; 2007 Jul; 107(1):136-44. PubMed ID: 17639883
[TBL] [Abstract][Full Text] [Related]
7. Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations.
Mahato RI; Takakura Y; Hashida M
Crit Rev Ther Drug Carrier Syst; 1997; 14(2):133-72. PubMed ID: 9107520
[TBL] [Abstract][Full Text] [Related]
8. From genes to gene medicines: recent advances in nonviral gene delivery.
Rolland AP
Crit Rev Ther Drug Carrier Syst; 1998; 15(2):143-98. PubMed ID: 9592627
[TBL] [Abstract][Full Text] [Related]
9. A direct in vivo approach for skin gene therapy.
Vogel JC
Proc Assoc Am Physicians; 1999; 111(3):190-7. PubMed ID: 10354358
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of naked DNA uptake and expression.
Wolff JA; Budker V
Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
[TBL] [Abstract][Full Text] [Related]
11. Nonviral Delivery Systems for Cancer Gene Therapy: Strategies and Challenges.
Shim G; Kim D; Le QV; Park GT; Kwon T; Oh YK
Curr Gene Ther; 2018; 18(1):3-20. PubMed ID: 29357792
[TBL] [Abstract][Full Text] [Related]
12. Emerging vectors and targeting methods for nonviral gene therapy.
Lavigne MD; Górecki DC
Expert Opin Emerg Drugs; 2006 Sep; 11(3):541-57. PubMed ID: 16939390
[TBL] [Abstract][Full Text] [Related]
13. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
14. Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector.
Takahashi Y; Nishikawa M; Takakura Y
Front Biosci (Schol Ed); 2012 Jan; 4(1):133-41. PubMed ID: 22202048
[TBL] [Abstract][Full Text] [Related]
15. Contribution of poly(amino acids) to advances in pharmaceutical biotechnology.
Chiang CH; Yeh MK
Curr Pharm Biotechnol; 2003 Oct; 4(5):323-30. PubMed ID: 14529422
[TBL] [Abstract][Full Text] [Related]
16. DNA-Based Nonviral Gene Therapy─Challenging but Promising.
Guan X; Pei Y; Song J
Mol Pharm; 2024 Feb; 21(2):427-453. PubMed ID: 38198640
[TBL] [Abstract][Full Text] [Related]
17. Purification of plasmids for gene therapy and DNA vaccination.
Prazeres DM; Monteiro GA; Ferreira GN; Diogo MM; Ribeiro SC; Cabral JM
Biotechnol Annu Rev; 2001; 7():1-30. PubMed ID: 11686041
[TBL] [Abstract][Full Text] [Related]
18. Cationic lipid-based gene delivery systems: pharmaceutical perspectives.
Mahato RI; Rolland A; Tomlinson E
Pharm Res; 1997 Jul; 14(7):853-9. PubMed ID: 9244140
[TBL] [Abstract][Full Text] [Related]
19. Recent developments and perspectives on gene therapy using synthetic vectors.
Schlenk F; Grund S; Fischer D
Ther Deliv; 2013 Jan; 4(1):95-113. PubMed ID: 23323783
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives.
Panje CM; Wang DS; Willmann JK
Invest Radiol; 2013 Nov; 48(11):755-69. PubMed ID: 23697924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
